Angiotensin II receptor antagonists - PDFSEARCH.IO - Document Search Engine

Angiotensin II receptor antagonists
Results: 290

#	Item
191	Bulletin # 827 February 1, 2012 NBPDP Formulary Update Please find attached lists of interchangeable product additions to the New Brunswick Prescription Add to Reading List Source URL: www.gnb.ca Language: English - Date: 2012-02-07 10:01:58 Organochlorides Tetrazoles Combination drugs Hydrochlorothiazide Thiazides Amlodipine Losartan Valsartan American Viticultural Area Chemistry Organic chemistry Angiotensin II receptor antagonists
192	Bulletin # 851 December 18, 2012 NBPDP Formulary Update Please find attached lists of interchangeable product additions to the New Brunswick Add to Reading List Source URL: www.gnb.ca Language: English - Date: 2012-12-18 08:38:12 Angiotensin II receptor antagonists Tetrazoles Alkynes Imidazoles Losartan Formulary Candesartan Levonorgestrel Ethinylestradiol Chemistry Organic chemistry Hormonal contraception
193	Bulletin # 844 October 17, 2012 NBPDP Formulary Update Please find attached lists of interchangeable product additions to the New Brunswick Add to Reading List Source URL: www.gnb.ca Language: English - Date: 2012-10-16 15:00:21 Angiotensin II receptor antagonists Carboxylic acids Alcohols Amides Valsartan Candesartan Hydrochlorothiazide Losartan Mylan Chemistry Organic chemistry Tetrazoles
194	Bulletin # 847 November 16, 2012 NBPDP Formulary Update Please find attached lists of interchangeable product additions to the New Brunswick Add to Reading List Source URL: www.gnb.ca Language: English - Date: 2012-11-16 14:42:08 Triptans Amides Novartis Valsartan Anastrozole Simvastatin Telmisartan SAS Hydrochlorothiazide Chemistry Organic chemistry Angiotensin II receptor antagonists
195	Bulletin # 883 March 31, 2014 NBPDP Formulary Update Please find attached a list of interchangeable product additions to the New Brunswick Add to Reading List Source URL: www.gnb.ca Language: English - Date: 2014-03-31 12:23:11 Combination drugs Amides Novartis Valsartan Hydrochlorothiazide HCT Citalopram Chemistry Organic chemistry Angiotensin II receptor antagonists
196	Bulletin #867 August 2, 2013 NBPDP FORMULARY UPDATE This update to the New Brunswick Prescription Drug Program (NBPDP) Formulary is effective Add to Reading List Source URL: www.gnb.ca Language: English - Date: 2013-08-02 12:28:13 Ethers Sulfonamides Protease inhibitors Angiotensin II receptor antagonists Candesartan Rosuvastatin Statin Darunavir Mylan Chemistry Organic chemistry Carboxylic acids
197	Bulletin # 856 March 19, 2013 NBPDP Formulary Update Please find attached a list of interchangeable product additions to the New Brunswick Add to Reading List Source URL: www.gnb.ca Language: English - Date: 2013-03-19 14:03:47 Tetrazoles Angiotensin II receptor antagonists Benzimidazoles Combination drugs Candesartan Hydrochlorothiazide Telmisartan/hydrochlorothiazide Irbesartan Rosuvastatin Chemistry Organic chemistry Carboxylic acids
198	Pediatric Focused Safety Review: ATACAND® (candesartan cilexitil) Pediatric Advisory Committee Meeting January 30, 2011 Nadia Hejazi, M.D., Medical Officer Add to Reading List Source URL: www.fda.gov Language: English Carboxylic acids Tetrazoles Ethers Benzimidazoles Candesartan Antihypertensive drug Hypertension Paracetamol Chemistry Organic chemistry Angiotensin II receptor antagonists
199	Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology Add to Reading List Source URL: www.fda.gov Language: English Carboxylic acids Tetrazoles Benzimidazoles Candesartan Ethers Medical prescription Methadone Pharmacy Chemistry Organic chemistry Angiotensin II receptor antagonists
200	Major Drug Manufacturer Novartis to Pay $422.5 Million to Settle Claims of Off-Label Drug Marketing and Kickbacks Add to Reading List Source URL: www.tn.gov Language: English - Date: 2011-07-20 17:30:31 Angiotensin II receptor antagonists Novartis Pharmaceuticals policy False Claims Act Pharmaceutical industry TennCare Medicaid Valsartan Tegaserod Chemistry Organic chemistry Pharmacology

UPDATE